81 results
S-8
KROS
Keros Therapeutics Inc
28 Feb 24
Registration of securities for employees
5:41pm
INSTRUCTION E
Keros Therapeutics, Inc. (the “Registran”) is filing this Registration Statement on Form S-8 for the purpose of registering (a) 1,273,643 … (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description; and
(c) All other reports and documents
8-K
EX-1.1
KROS
Keros Therapeutics Inc
4 Jan 24
Other Events
4:04pm
is in effect and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated or threatened … or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other person or entity, for the purpose of financing
424B5
KROS
Keros Therapeutics Inc
4 Jan 24
Prospectus supplement for primary offering
4:02pm
prospectus we have authorized for use in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United … , or may hold such proceeds as cash, until they are used for their stated purpose. As of the date of this prospectus supplement, we cannot specify
424B5
KROS
Keros Therapeutics Inc
3 Jan 24
Prospectus supplement for primary offering
4:04pm
or any free writing prospectus we have authorized for use in connection with this offering in any jurisdiction where action for that purpose is required … , investment-grade, interest-bearing instruments and U.S. government securities, or may hold such proceeds as cash, until they are used for their stated purpose
424B5
ugp3kel6 tl
12 Dec 22
Prospectus supplement for primary offering
4:02pm
S-8
513 2g3kuti7l
9 Mar 22
Registration of securities for employees
4:27pm
8-K
EX-10.1
wukwkn26kswaxrj0lcap
31 Jan 22
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
8:02am